Petros Pharmaceuticals In... (PTPI)
0.29
-0.00 (-0.38%)
At close: Jan 28, 2025, 1:55 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | 5.82M | 5.99M | 7.81M | 9.56M | 15.58M | 14.05M |
| Cost of Revenue | 1.63M | 2.29M | 1.60M | 4.05M | 7.43M | 10.48M |
| Gross Profit | 4.19M | 3.70M | 6.21M | 5.51M | 8.15M | 3.57M |
| Operating Income | -13.62M | -15.85M | -18.05M | -17.28M | -16.87M | -7.65M |
| Interest Income | 515.31K | 14.19K | 368.66K | 3.05M | 13.84M | 11.86M |
| Pretax Income | -8.16M | -20.04M | -8.99M | -22.01M | -33.16M | -32.49M |
| Net Income | -8.16M | -27.04M | -9.36M | -20.59M | -32.51M | -32.47M |
| Selling & General & Admin | 9.26M | 12.21M | 15.59M | 15.67M | 19.73M | 11.22M |
| Research & Development | 2.41M | 1.74M | 1.79M | 459.64K | n/a | n/a |
| Other Expenses | 6.14M | 5.60M | 6.88M | 6.66M | 5.29M | n/a |
| Operating Expenses | 17.81M | 19.55M | 24.26M | 22.80M | 25.02M | 11.22M |
| Interest Expense | 536.14K | 596.02K | 368.66K | 3.05M | 13.84M | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -41.15K |
| Cost & Expenses | 19.44M | 21.84M | 25.86M | 26.84M | 32.45M | 21.70M |
| Income Tax | n/a | 7.00M | 368.66K | -1.43M | -645.87K | -13.37K |
| Shares Outstanding (Basic) | 2.18M | 2.07M | 1.09M | 970.76K | 170.70K | 100.00K |
| Shares Outstanding (Diluted) | 2.18M | 2.07M | 1.09M | 970.76K | 170.70K | 100.00K |
| EPS (Basic) | -6.35 | -13.06 | -8.59 | -21.21 | -190.46 | -324.73 |
| EPS (Diluted) | -6.35 | -13.06 | -8.59 | -21.21 | -190.46 | -324.73 |
| EBITDA | -4.21M | -13.73M | -1.64M | -12.21M | -14.00M | 373.58K |
| Depreciation & Amortization | 3.42M | 5.72M | 6.98M | 6.75M | 5.32M | 8.06M |